[{"AccountsPayableCurrent_0_Q3_USD":5511000.0,"OtherAssetsNoncurrent_0_Q3_USD":6243000.0,"OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_1_Q3_USD":0.0,"OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":202000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":339000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":201000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":201000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":362000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-1000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":23000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q3_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_3_Q3_USD":0.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-69000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-175000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":128984000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1497000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":210000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.075,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":40763000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":13937000.0,"LettersOfCreditOutstandingAmount_0_Q3_USD":1800000.0,"Liabilities_0_Q3_USD":113504000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":383284000.0,"LiabilitiesCurrent_0_Q3_USD":23572000.0,"MarketableSecuritiesCurrent_0_Q3_USD":75513000.0,"MarketableSecuritiesNoncurrent_0_Q3_USD":20739000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":35918000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-34899000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-80243000.0,"NetIncomeLoss_1_Q3_USD":-30696000.0,"NetIncomeLoss_3_Q3_USD":-110482000.0,"OperatingIncomeLoss_1_Q3_USD":-31006000.0,"OperatingIncomeLoss_3_Q3_USD":-111427000.0,"OperatingLeaseExpense_3_Q3_USD":4134000.0,"OperatingLeaseLiability_0_Q3_USD":44957000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":4194000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":56948000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockValue_0_Q3_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":25980000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":6209000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":13.04,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":25980000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":6209000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":13.04,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":6.17,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":29.27,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":15.49,"StockholdersEquity_0_Q3_USD":269780000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":281000.0,"VariableLeaseCost_1_Q3_USD":500000.0,"VariableLeaseCost_3_Q3_USD":1700000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":43563000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":44661000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q3_shares":136000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_3_Q3_shares":159000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":10.53,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1371000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":395000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":2864000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":2496000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":2027000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":95315000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":267000.0,"ProfitLoss_3_Q3_USD":-110482000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":22642000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":19327000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":23573000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1778000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":72057000.0,"RestrictedCashNoncurrent_0_Q3_USD":2074000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-239311000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":4000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":389000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q3_shares":1400000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":13193000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":2374000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":16.2,"RestrictedCash_0_Q3_USD":2074000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":7695000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":7850000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":8009000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":75513000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":96252000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q3_USD":167000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":21563000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":4670000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":116000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":108522000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":108522000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":110596000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-78904000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockSharesAuthorized_0_Q3_shares":300000000.0,"CommonStockSharesIssued_0_Q3_shares":44830000.0,"CommonStockSharesOutstanding_0_Q3_shares":44830000.0,"CommonStockValue_0_Q3_USD":4000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-30495000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q3_USD":75513000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q3_USD":0.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":96250000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":9000.0,"AccountsReceivableGrossCurrent_0_Q3_USD":11000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-63000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":5154000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":13867000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":3315000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":373000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":508714000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":3287000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-110120000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":3287000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":423000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":1265000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":7235000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":7235000.0,"Assets_0_Q3_USD":383284000.0,"AssetsCurrent_0_Q3_USD":186542000.0,"AssetsFairValueDisclosure_0_Q3_USD":204774000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":11000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":9360000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":44797000.0,"DeferredIncomeTaxesAndTaxCredits_3_Q3_USD":-1204000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.69,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":-111602000.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":-84000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":-84000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-463000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-1204000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":1822000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-250000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":-1968000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-95000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-2153000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q3_USD":64668000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":62982000.0,"InvestmentsFairValueDisclosure_0_Q3_USD":96252000.0,"LeaseAndRentalExpense_1_Q3_USD":2400000.0,"LeaseAndRentalExpense_3_Q3_USD":6400000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":58894000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":7483000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":-31075000.0,"Goodwill_0_Q3_USD":18541000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":24158000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":6847000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.54,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.015,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.011,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3_Q3_pure":0.21,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":320000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":26800000.0,"EquityMethodInvestmentRealizedGainLossOnDisposal_3_Q3_USD":7227000.0,"EquityMethodInvestments_0_Q3_USD":9888000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":15172000.0,"FinancialLiabilitiesFairValueDisclosure_0_Q3_USD":33997000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":1722000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":423000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":1733000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":1733000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":1733000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":28118000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":26432000.0,"GainLossOnDispositionOfAssets1_3_Q3_USD":7227000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":1686000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":43722000.0,"Ticker":"KDNY","CIK":"1435049","name":"CHINOOK THERAPEUTICS, INC.","OfficialName":"Chinook Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"858364832.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211108"}]